跳转至内容
Merck
CN
所有图片(1)

主要文件

30906

Sigma-Aldrich

蓖麻油，乙氧基化

别名:

PEG-35 蓖麻油, 聚氧乙烯蓖麻油

登录查看公司和协议定价
所有图片(1)

About This Item

CAS号:
61791-12-6
MDL编号:
MFCD00130879
UNSPSC代码:
12161900
NACRES:
NA.25

描述

non-ionic

质量水平

100

表单

paste

杂质

alkalinity, complies
≤ acetic acid (≤0.5 g/100g (%) verfied on random samples only)
≤0.1% oleic acid
≤0.1% palmitic acid
≤0.2% sulfated ash (verfied on random samples only)
≤0.20% ricinoleic acid
≤0.5% water
≤1 ppm ethylene oxide (verfied on random samples only)
≤1.0% free fatty acids
≤10 ppm dioxan (verfied on random samples only)
≤10 ppm heavy metals (verfied on random samples only)
≤620 ppm diethylene glycol (verfied on random samples only)
≤620 ppm ethylene glycol (verfied on random samples only)

灼烧残渣

≤0.2%

pH值（酸碱度）

5.0-7.0 (1 g/10 mL in H2O)

粘度

600-750 mPa.s(25 °C)

酸值

≤2.0 mg KOH/g

羟基值

65‑78 mg KOH/g

碘值

25‑35 g/100g

皂化值

65‑70 mg KOH/g

痕量阳离子

K: ≤15 ppm

SMILES字符串

ClCC(OC(=O)N)CCl

InChI

1S/C4H7Cl2NO2/c5-1-3(2-6)9-4(7)8/h3H,1-2H2,(H2,7,8)

InChI key

JMNCUXPHXKHBPY-UHFFFAOYSA-N

相关类别

应用

乙氧基化蓖麻油可用于乳化和溶解油类和其它不溶于水的物质。 与乙氧基化蓖麻油相似，但含水量较低，且粘度不同。

分析说明

相对密度 D (25/25) 1.05-1.06

法律信息

Cremophor is a registered trademark of BASF SE

储存分类代码

11 - Combustible Solids

WGK

WGK 1

闪点(°F)

494.6 °F - Not applicable

闪点(°C)

257 °C - Not applicable

从最新的版本中选择一种：

分析证书(COA)

Lot/Batch Number
BCCM1629
BCCL5129
BCCK7446
BCCH6408
BCCG7682

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Enas A Mahmoud et al.
AAPS PharmSciTech, 10(1), 183-192 (2009-02-25)
The purpose of this study was to combine the advantages of self-nanoemulsifying drug delivery systems and tablets as a conventional dosage form emphasizing the excipients' effect on the development of a new dosage form. Systems composed of HCO-40, Transcutol HP
Siva Narayanan et al.
Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society, 32(3), 163-170 (2005-06-03)
This study compared clinical outcomes and nursing labor costs associated with (a) balsam Peru, hydrogenated castor oil, and trypsin (BCT) ointment; (b) BCT + Other; and (c) Other treatments in 2014 wound episodes occurring in 861 patients (mean 2.34 wounds/patient).
Hideki Ichikawa et al.
Current drug delivery, 4(2), 131-140 (2007-04-26)
The effects of the formulation and particle composition of gadolinium (Gd)-containing lipid nanoemulsion (Gd-nanoLE) on the biodistribution of Gd after its intravenous (IV) injection in D(1)-179 melanoma-bearing hamsters were evaluated for its application in cancer neutron-capture therapy. Gd-nanoLEs whose particles
Ravouru Nagaraju et al.
Current drug discovery technologies, 6(4), 299-305 (2009-12-23)
The core-in-cup matrix tablets of Metoprolol succinate were prepared by wet granulation technique. Of all the investigated formulations, the optimized formulation of MS-09 followed zero-order kinetics of drug release. Trail on MS-09 was formulated using 7.5% hydrogenated castor-oil (HCO) and
Ming-Kung Yeh et al.
AAPS PharmSciTech, 10(1), 166-171 (2009-02-19)
The formulation study of tenoxicam, a poorly water-soluble drug, was developed by use of a ternary cosolvent system and has significantly enhanced the solubility. Additionally, the relative bioavailability of testing formulation was also evaluated by New Zealand rabbit with a
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门